Industry Research Reports

Home > Reports > Medical Care > Third-party Pathology Diagnosis Center- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Third-party Pathology Diagnosis Center- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-09-28

Pages: 81 Pages

Report ld: 3333403

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

A third-party pathology diagnosis center is an independent legal entity that provides pathology diagnostic services and issues formal pathology reports. These centers are distinct from in-house pathology departments within medical institutions and serve a variety of healthcare providers, including hospitals and clinics. They are responsible for analyzing and diagnosing pathology samples and assume the corresponding legal responsibilities. By offering high-quality diagnostic services, these centers assist medical institutions in making accurate diagnostic and treatment decisions.

The global market for Third-party Pathology Diagnosis Center was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.

North American market for Third-party Pathology Diagnosis Center was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Third-party Pathology Diagnosis Center was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Third-party Pathology Diagnosis Center was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Third-party Pathology Diagnosis Center include Unilabs, Quest Diagnostics, Sonic Healthcare, LabCorp, SYNLAB, HISTO, Fen Lan Medical, Akmpath, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

The Third-party Pathology Diagnosis Center market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Third-party Pathology Diagnosis Center.

Market Segmentation

Report Metric
Details
Report Title
Third-party Pathology Diagnosis Center- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Third-party Pathology Diagnosis Center Companies Covered
Unilabs, Quest Diagnostics, Sonic Healthcare, LabCorp, SYNLAB, HISTO, Fen Lan Medical, Akmpath
Global Third-party Pathology Diagnosis Center Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Third-party Pathology Diagnosis Center Market, Segment by Type
Third-Party Medical Testing Laboratory

Independent Third-Party Pathology Diagnosis Center
Global Third-party Pathology Diagnosis Center Market, Segment by Application
Hospital

Clinic

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Third-party Pathology Diagnosis Center company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Third-party Pathology Diagnosis Center in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Third-party Pathology Diagnosis Center in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Third-party Pathology Diagnosis Center Product Introduction
    1.2 Global Third-party Pathology Diagnosis Center Market Size Forecast (2019-2030)
    1.3 Third-party Pathology Diagnosis Center Market Trends & Drivers
        1.3.1 Third-party Pathology Diagnosis Center Industry Trends
        1.3.2 Third-party Pathology Diagnosis Center Market Drivers & Opportunity
        1.3.3 Third-party Pathology Diagnosis Center Market Challenges
        1.3.4 Third-party Pathology Diagnosis Center Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Third-party Pathology Diagnosis Center Players Revenue Ranking (2023)
    2.2 Global Third-party Pathology Diagnosis Center Revenue by Company (2019-2024)
    2.3 Key Companies Third-party Pathology Diagnosis Center Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Third-party Pathology Diagnosis Center Product Offered
    2.5 Key Companies Time to Begin Mass Production of Third-party Pathology Diagnosis Center
    2.6 Third-party Pathology Diagnosis Center Market Competitive Analysis
        2.6.1 Third-party Pathology Diagnosis Center Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Third-party Pathology Diagnosis Center Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Third-party Pathology Diagnosis Center as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Third-Party Medical Testing Laboratory
        3.1.2 Independent Third-Party Pathology Diagnosis Center
    3.2 Global Third-party Pathology Diagnosis Center Sales Value by Type
        3.2.1 Global Third-party Pathology Diagnosis Center Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Third-party Pathology Diagnosis Center Sales Value, by Type (2019-2030)
        3.2.3 Global Third-party Pathology Diagnosis Center Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Other
    4.2 Global Third-party Pathology Diagnosis Center Sales Value by Application
        4.2.1 Global Third-party Pathology Diagnosis Center Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Third-party Pathology Diagnosis Center Sales Value, by Application (2019-2030)
        4.2.3 Global Third-party Pathology Diagnosis Center Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Third-party Pathology Diagnosis Center Sales Value by Region
        5.1.1 Global Third-party Pathology Diagnosis Center Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Third-party Pathology Diagnosis Center Sales Value by Region (2019-2024)
        5.1.3 Global Third-party Pathology Diagnosis Center Sales Value by Region (2025-2030)
        5.1.4 Global Third-party Pathology Diagnosis Center Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Third-party Pathology Diagnosis Center Sales Value, 2019-2030
        5.2.2 North America Third-party Pathology Diagnosis Center Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Third-party Pathology Diagnosis Center Sales Value, 2019-2030
        5.3.2 Europe Third-party Pathology Diagnosis Center Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Third-party Pathology Diagnosis Center Sales Value, 2019-2030
        5.4.2 Asia Pacific Third-party Pathology Diagnosis Center Sales Value by Region (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Third-party Pathology Diagnosis Center Sales Value, 2019-2030
        5.5.2 South America Third-party Pathology Diagnosis Center Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Third-party Pathology Diagnosis Center Sales Value, 2019-2030
        5.6.2 Middle East & Africa Third-party Pathology Diagnosis Center Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Third-party Pathology Diagnosis Center Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Third-party Pathology Diagnosis Center Sales Value, 2019-2030
    6.3 United States
        6.3.1 United States Third-party Pathology Diagnosis Center Sales Value, 2019-2030
        6.3.2 United States Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Third-party Pathology Diagnosis Center Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Third-party Pathology Diagnosis Center Sales Value, 2019-2030
        6.4.2 Europe Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Third-party Pathology Diagnosis Center Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Third-party Pathology Diagnosis Center Sales Value, 2019-2030
        6.5.2 China Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Third-party Pathology Diagnosis Center Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Third-party Pathology Diagnosis Center Sales Value, 2019-2030
        6.6.2 Japan Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Third-party Pathology Diagnosis Center Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Third-party Pathology Diagnosis Center Sales Value, 2019-2030
        6.7.2 South Korea Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Third-party Pathology Diagnosis Center Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Third-party Pathology Diagnosis Center Sales Value, 2019-2030
        6.8.2 Southeast Asia Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Third-party Pathology Diagnosis Center Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Third-party Pathology Diagnosis Center Sales Value, 2019-2030
        6.9.2 India Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Third-party Pathology Diagnosis Center Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Unilabs
        7.1.1 Unilabs Profile
        7.1.2 Unilabs Main Business
        7.1.3 Unilabs Third-party Pathology Diagnosis Center Products, Services and Solutions
        7.1.4 Unilabs Third-party Pathology Diagnosis Center Revenue (US$ Million) & (2019-2024)
        7.1.5 Unilabs Recent Developments
    7.2 Quest Diagnostics
        7.2.1 Quest Diagnostics Profile
        7.2.2 Quest Diagnostics Main Business
        7.2.3 Quest Diagnostics Third-party Pathology Diagnosis Center Products, Services and Solutions
        7.2.4 Quest Diagnostics Third-party Pathology Diagnosis Center Revenue (US$ Million) & (2019-2024)
        7.2.5 Quest Diagnostics Recent Developments
    7.3 Sonic Healthcare
        7.3.1 Sonic Healthcare Profile
        7.3.2 Sonic Healthcare Main Business
        7.3.3 Sonic Healthcare Third-party Pathology Diagnosis Center Products, Services and Solutions
        7.3.4 Sonic Healthcare Third-party Pathology Diagnosis Center Revenue (US$ Million) & (2019-2024)
        7.3.5 Sonic Healthcare Recent Developments
    7.4 LabCorp
        7.4.1 LabCorp Profile
        7.4.2 LabCorp Main Business
        7.4.3 LabCorp Third-party Pathology Diagnosis Center Products, Services and Solutions
        7.4.4 LabCorp Third-party Pathology Diagnosis Center Revenue (US$ Million) & (2019-2024)
        7.4.5 LabCorp Recent Developments
    7.5 SYNLAB
        7.5.1 SYNLAB Profile
        7.5.2 SYNLAB Main Business
        7.5.3 SYNLAB Third-party Pathology Diagnosis Center Products, Services and Solutions
        7.5.4 SYNLAB Third-party Pathology Diagnosis Center Revenue (US$ Million) & (2019-2024)
        7.5.5 SYNLAB Recent Developments
    7.6 HISTO
        7.6.1 HISTO Profile
        7.6.2 HISTO Main Business
        7.6.3 HISTO Third-party Pathology Diagnosis Center Products, Services and Solutions
        7.6.4 HISTO Third-party Pathology Diagnosis Center Revenue (US$ Million) & (2019-2024)
        7.6.5 HISTO Recent Developments
    7.7 Fen Lan Medical
        7.7.1 Fen Lan Medical Profile
        7.7.2 Fen Lan Medical Main Business
        7.7.3 Fen Lan Medical Third-party Pathology Diagnosis Center Products, Services and Solutions
        7.7.4 Fen Lan Medical Third-party Pathology Diagnosis Center Revenue (US$ Million) & (2019-2024)
        7.7.5 Fen Lan Medical Recent Developments
    7.8 Akmpath
        7.8.1 Akmpath Profile
        7.8.2 Akmpath Main Business
        7.8.3 Akmpath Third-party Pathology Diagnosis Center Products, Services and Solutions
        7.8.4 Akmpath Third-party Pathology Diagnosis Center Revenue (US$ Million) & (2019-2024)
        7.8.5 Akmpath Recent Developments

 8 Industry Chain Analysis
    8.1 Third-party Pathology Diagnosis Center Industrial Chain
    8.2 Third-party Pathology Diagnosis Center Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Third-party Pathology Diagnosis Center Sales Model
        8.5.2 Sales Channel
        8.5.3 Third-party Pathology Diagnosis Center Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Third-party Pathology Diagnosis Center Market Trends
 Table 2. Third-party Pathology Diagnosis Center Market Drivers & Opportunity
 Table 3. Third-party Pathology Diagnosis Center Market Challenges
 Table 4. Third-party Pathology Diagnosis Center Market Restraints
 Table 5. Global Third-party Pathology Diagnosis Center Revenue by Company (2019-2024) & (US$ Million)
 Table 6. Global Third-party Pathology Diagnosis Center Revenue Market Share by Company (2019-2024)
 Table 7. Key Companies Third-party Pathology Diagnosis Center Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Third-party Pathology Diagnosis Center Product Type
 Table 9. Key Companies Time to Begin Mass Production of Third-party Pathology Diagnosis Center
 Table 10. Global Third-party Pathology Diagnosis Center Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Third-party Pathology Diagnosis Center as of 2023)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Third-party Pathology Diagnosis Center Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 14. Global Third-party Pathology Diagnosis Center Sales Value by Type (2019-2024) & (US$ Million)
 Table 15. Global Third-party Pathology Diagnosis Center Sales Value by Type (2025-2030) & (US$ Million)
 Table 16. Global Third-party Pathology Diagnosis Center Sales Market Share in Value by Type (2019-2024)
 Table 17. Global Third-party Pathology Diagnosis Center Sales Market Share in Value by Type (2025-2030)
 Table 18. Global Third-party Pathology Diagnosis Center Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 19. Global Third-party Pathology Diagnosis Center Sales Value by Application (2019-2024) & (US$ Million)
 Table 20. Global Third-party Pathology Diagnosis Center Sales Value by Application (2025-2030) & (US$ Million)
 Table 21. Global Third-party Pathology Diagnosis Center Sales Market Share in Value by Application (2019-2024)
 Table 22. Global Third-party Pathology Diagnosis Center Sales Market Share in Value by Application (2025-2030)
 Table 23. Global Third-party Pathology Diagnosis Center Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
 Table 24. Global Third-party Pathology Diagnosis Center Sales Value by Region (2019-2024) & (US$ Million)
 Table 25. Global Third-party Pathology Diagnosis Center Sales Value by Region (2025-2030) & (US$ Million)
 Table 26. Global Third-party Pathology Diagnosis Center Sales Value by Region (2019-2024) & (%)
 Table 27. Global Third-party Pathology Diagnosis Center Sales Value by Region (2025-2030) & (%)
 Table 28. Key Countries/Regions Third-party Pathology Diagnosis Center Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
 Table 29. Key Countries/Regions Third-party Pathology Diagnosis Center Sales Value, (2019-2024) & (US$ Million)
 Table 30. Key Countries/Regions Third-party Pathology Diagnosis Center Sales Value, (2025-2030) & (US$ Million)
 Table 31. Unilabs Basic Information List
 Table 32. Unilabs Description and Business Overview
 Table 33. Unilabs Third-party Pathology Diagnosis Center Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Third-party Pathology Diagnosis Center Business of Unilabs (2019-2024)
 Table 35. Unilabs Recent Developments
 Table 36. Quest Diagnostics Basic Information List
 Table 37. Quest Diagnostics Description and Business Overview
 Table 38. Quest Diagnostics Third-party Pathology Diagnosis Center Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Third-party Pathology Diagnosis Center Business of Quest Diagnostics (2019-2024)
 Table 40. Quest Diagnostics Recent Developments
 Table 41. Sonic Healthcare Basic Information List
 Table 42. Sonic Healthcare Description and Business Overview
 Table 43. Sonic Healthcare Third-party Pathology Diagnosis Center Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Third-party Pathology Diagnosis Center Business of Sonic Healthcare (2019-2024)
 Table 45. Sonic Healthcare Recent Developments
 Table 46. LabCorp Basic Information List
 Table 47. LabCorp Description and Business Overview
 Table 48. LabCorp Third-party Pathology Diagnosis Center Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Third-party Pathology Diagnosis Center Business of LabCorp (2019-2024)
 Table 50. LabCorp Recent Developments
 Table 51. SYNLAB Basic Information List
 Table 52. SYNLAB Description and Business Overview
 Table 53. SYNLAB Third-party Pathology Diagnosis Center Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Third-party Pathology Diagnosis Center Business of SYNLAB (2019-2024)
 Table 55. SYNLAB Recent Developments
 Table 56. HISTO Basic Information List
 Table 57. HISTO Description and Business Overview
 Table 58. HISTO Third-party Pathology Diagnosis Center Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Third-party Pathology Diagnosis Center Business of HISTO (2019-2024)
 Table 60. HISTO Recent Developments
 Table 61. Fen Lan Medical Basic Information List
 Table 62. Fen Lan Medical Description and Business Overview
 Table 63. Fen Lan Medical Third-party Pathology Diagnosis Center Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Third-party Pathology Diagnosis Center Business of Fen Lan Medical (2019-2024)
 Table 65. Fen Lan Medical Recent Developments
 Table 66. Akmpath Basic Information List
 Table 67. Akmpath Description and Business Overview
 Table 68. Akmpath Third-party Pathology Diagnosis Center Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Third-party Pathology Diagnosis Center Business of Akmpath (2019-2024)
 Table 70. Akmpath Recent Developments
 Table 71. Key Raw Materials Lists
 Table 72. Raw Materials Key Suppliers Lists
 Table 73. Third-party Pathology Diagnosis Center Downstream Customers
 Table 74. Third-party Pathology Diagnosis Center Distributors List
 Table 75. Research Programs/Design for This Report
 Table 76. Key Data Information from Secondary Sources
 Table 77. Key Data Information from Primary Sources
 Table 78. Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Third-party Pathology Diagnosis Center Product Picture
 Figure 2. Global Third-party Pathology Diagnosis Center Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Third-party Pathology Diagnosis Center Sales Value (2019-2030) & (US$ Million)
 Figure 4. Third-party Pathology Diagnosis Center Report Years Considered
 Figure 5. Global Third-party Pathology Diagnosis Center Players Revenue Ranking (2023) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Third-party Pathology Diagnosis Center Revenue in 2023
 Figure 7. Third-party Pathology Diagnosis Center Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 8. Third-Party Medical Testing Laboratory Picture
 Figure 9. Independent Third-Party Pathology Diagnosis Center Picture
 Figure 10. Global Third-party Pathology Diagnosis Center Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 11. Global Third-party Pathology Diagnosis Center Sales Value Market Share by Type, 2023 & 2030
 Figure 12. Product Picture of Hospital
 Figure 13. Product Picture of Clinic
 Figure 14. Product Picture of Other
 Figure 15. Global Third-party Pathology Diagnosis Center Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 16. Global Third-party Pathology Diagnosis Center Sales Value Market Share by Application, 2023 & 2030
 Figure 17. North America Third-party Pathology Diagnosis Center Sales Value (2019-2030) & (US$ Million)
 Figure 18. North America Third-party Pathology Diagnosis Center Sales Value by Country (%), 2023 VS 2030
 Figure 19. Europe Third-party Pathology Diagnosis Center Sales Value, (2019-2030) & (US$ Million)
 Figure 20. Europe Third-party Pathology Diagnosis Center Sales Value by Country (%), 2023 VS 2030
 Figure 21. Asia Pacific Third-party Pathology Diagnosis Center Sales Value, (2019-2030) & (US$ Million)
 Figure 22. Asia Pacific Third-party Pathology Diagnosis Center Sales Value by Region (%), 2023 VS 2030
 Figure 23. South America Third-party Pathology Diagnosis Center Sales Value, (2019-2030) & (US$ Million)
 Figure 24. South America Third-party Pathology Diagnosis Center Sales Value by Country (%), 2023 VS 2030
 Figure 25. Middle East & Africa Third-party Pathology Diagnosis Center Sales Value, (2019-2030) & (US$ Million)
 Figure 26. Middle East & Africa Third-party Pathology Diagnosis Center Sales Value by Country (%), 2023 VS 2030
 Figure 27. Key Countries/Regions Third-party Pathology Diagnosis Center Sales Value (%), (2019-2030)
 Figure 28. United States Third-party Pathology Diagnosis Center Sales Value, (2019-2030) & (US$ Million)
 Figure 29. United States Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
 Figure 30. United States Third-party Pathology Diagnosis Center Sales Value by Application (%), 2023 VS 2030
 Figure 31. Europe Third-party Pathology Diagnosis Center Sales Value, (2019-2030) & (US$ Million)
 Figure 32. Europe Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
 Figure 33. Europe Third-party Pathology Diagnosis Center Sales Value by Application (%), 2023 VS 2030
 Figure 34. China Third-party Pathology Diagnosis Center Sales Value, (2019-2030) & (US$ Million)
 Figure 35. China Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
 Figure 36. China Third-party Pathology Diagnosis Center Sales Value by Application (%), 2023 VS 2030
 Figure 37. Japan Third-party Pathology Diagnosis Center Sales Value, (2019-2030) & (US$ Million)
 Figure 38. Japan Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
 Figure 39. Japan Third-party Pathology Diagnosis Center Sales Value by Application (%), 2023 VS 2030
 Figure 40. South Korea Third-party Pathology Diagnosis Center Sales Value, (2019-2030) & (US$ Million)
 Figure 41. South Korea Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
 Figure 42. South Korea Third-party Pathology Diagnosis Center Sales Value by Application (%), 2023 VS 2030
 Figure 43. Southeast Asia Third-party Pathology Diagnosis Center Sales Value, (2019-2030) & (US$ Million)
 Figure 44. Southeast Asia Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
 Figure 45. Southeast Asia Third-party Pathology Diagnosis Center Sales Value by Application (%), 2023 VS 2030
 Figure 46. India Third-party Pathology Diagnosis Center Sales Value, (2019-2030) & (US$ Million)
 Figure 47. India Third-party Pathology Diagnosis Center Sales Value by Type (%), 2023 VS 2030
 Figure 48. India Third-party Pathology Diagnosis Center Sales Value by Application (%), 2023 VS 2030
 Figure 49. Third-party Pathology Diagnosis Center Industrial Chain
 Figure 50. Third-party Pathology Diagnosis Center Manufacturing Cost Structure
 Figure 51. Channels of Distribution (Direct Sales, and Distribution)
 Figure 52. Bottom-up and Top-down Approaches for This Report
 Figure 53. Data Triangulation
 Figure 54. Key Executives Interviewed

Description

A third-party pathology diagnosis center is an independent legal entity that provides pathology diagnostic services and issues formal pathology reports. These centers are distinct from in-house pathology departments within medical institutions and serve a variety of healthcare providers, including hospitals and clinics. They are responsible for analyzing and diagnosing pathology samples and assume the corresponding legal responsibilities. By offering high-quality diagnostic services, these centers assist medical institutions in making accurate diagnostic and treatment decisions.

The global market for Third-party Pathology Diagnosis Center was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.

North American market for Third-party Pathology Diagnosis Center was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Third-party Pathology Diagnosis Center was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Third-party Pathology Diagnosis Center was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Third-party Pathology Diagnosis Center include Unilabs, Quest Diagnostics, Sonic Healthcare, LabCorp, SYNLAB, HISTO, Fen Lan Medical, Akmpath, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

The Third-party Pathology Diagnosis Center market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Third-party Pathology Diagnosis Center.

Market Segmentation